All blog posts
Showing 12 out of 90 results
27 四月 2026
The EU Pharma Package is finally here – here's the settled position on key areas
12 三月 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
15 十二月 2025
A new era for EU pharmaceutical law: political agreement reached on the reform
09 十二月 2025
Preserving the status quo: Boehringer Ingelheim awarded interim injunction
15 十月 2025
Venture investment in life sciences – Activity update & outlook (US & Europe)
24 九月 2025
Biopharma M&A activity – strategics continue to lead the way
28 八月 2025
The Thursday Investment Club: The case for later living
18 八月 2025
Pharma remains an enforcement focus in China – SAMR orders unwinding of a completed pharma deal
31 七月 2025
EU Regulatory Reform for Medicinal Products: Bolar exemption
22 七月 2025
Overview of EU regulatory and competition law in the Pharma sector
13 五月 2025
EU Regulatory Reform for Medicinal Products: Changes to MAs, supply, and transparency
30 四月 2025
Reforms to the EU Regulatory framework for medicinal products
Showing 12 out of 90 results
View moreKey contacts
Laura Orlando
Managing Partner, Milan Office, Milan
Alan Montgomery
Partner, Head of Pharmaceuticals Sector, Chair of India Group, London and India Group
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London and Africa Group